As the report in Farmaindustria magazine indicates, incremental innovation in medicines is a growing need, both for patients and healthcare professionals. This has the essential purpose of facilitating the use and efficacy of medicines, and, especially, of improving the quality of life of people.
For this reason, drug reformulation technologies such as #DELOS are increasingly relevant in the sector. Incremental innovations are meeting an increasing demand and help in different aspects, which we could summarize in four: providing faster action, ease of use, and improvements in the efficacy and adherence of patients to their treatments. In addition, through incremental innovation, new routes of administration, and improvements in safety or dosage, can also be discovered, as well as the combination of two or more active ingredients that allow to use them more effectively.
At Nanomol Technologies we have developed our own formulation technology called DELOS. #DELOS enables the development of advanced nanomedicines and tailored drug delivery systems. We are able to stabilize and improve the performance of #APIs, from small chemical molecules to biologics , including peptides, proteins and intracellular delivery of nucleic acids, of interest to our partners, enabling new routes of administration or improved drug products.
If you are looking for an improvement in the formulation of your drug products, our technology can offer you many advantages in the market.